ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,059 | +44.9% | 3,760 | +64.1% | 0.00% | – |
| Q2 2023 | $70,425 | -64.7% | 2,291 | -58.6% | 0.00% | – |
| Q1 2023 | $199,570 | +16.0% | 5,539 | +27.2% | 0.00% | – |
| Q4 2022 | $172,110 | -14.4% | 4,355 | -12.6% | 0.00% | – |
| Q3 2022 | $201,000 | -59.7% | 4,981 | -58.0% | 0.00% | -100.0% |
| Q2 2022 | $499,000 | +15.2% | 11,870 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $433,000 | +44.8% | 11,105 | +48.1% | 0.00% | – |
| Q4 2021 | $299,000 | +686.8% | 7,497 | +707.9% | 0.00% | – |
| Q2 2021 | $38,000 | -2.6% | 928 | +2.5% | 0.00% | – |
| Q1 2021 | $39,000 | -13.3% | 905 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +18.4% | 905 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -13.6% | 905 | 0.0% | 0.00% | – |
| Q2 2020 | $44,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |